AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LUMOS DIAGNOSTICS HOLDINGS L

0.105

0.000

Volume:769.56K

Turnover:80.63K

Market Cap:99.16M

PE:-5.83

High:0.110

Open:0.110

Low:0.100

Close:0.105

52wk High:0.330

52wk Low:0.076

Shares:944.39M

Float Shares:375.60M

Volume Ratio:1.38

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.018

EPS(LYR):-0.011

ROE:-123.27%

ROA:-29.18%

PB:13.58

PE(LYR):-9.94

Loading ...

Overview Company News Filings

Lumos Diagnostics Secures Three-Year Contract to Manufacture Mold Analyzer; Shares Up 3%

MT Newswires Live

Lumos Diagnostics - First Purchase Order of a$250,000 Under Three-Year Contract

THOMSON REUTERS

Lumos Diagnostics Holdings Ltd - Secures Contract to Manufacture Micro-Pak Mold Analyzer System

THOMSON REUTERS

Lumos Diagnostics Holdings Receives Largest Ever Purchase Order of $1.3 Million, Shares Up 9%

MT Newswires Live

BRIEF-Lumos Diagnostics Receives Largest Febridx Order To Date

Lumos Diagnostics Holdings Ltd - Lumos Receives Largest Febridx Order to Date

THOMSON REUTERS

Lumos Diagnostics - Phase Lodges Purchase Order Valued at US$1.3 Mln for Febridx

THOMSON REUTERS

Lumos Diagnostics to Raise AU$20 Million via Share Placement

MT Newswires Live

BRIEF-Lumos Diagnostics Announces Share Purchase Plan To Raise About A$2.0 Million

BUZZ-Australia's Lumos Diagnostics gains as US FDA grants waiver for FebriDx

Lumos Diagnostics Holdings - Announces Share Purchase Plan to Raise About a$2.0 Mln

THOMSON REUTERS

Lumos Diagnostics - Offer Price at a$0.225 per Share

THOMSON REUTERS

Lumos Diagnostics Holdings Ltd - US FDA Grants Clia Waiver for Febridx

THOMSON REUTERS

BRIEF-Lumos Diagnostics Seeks Trading Halt Pending Update On FDA Response

Lumos Diagnostics Holdings - Seeks Trading Halt Pending Update on FDA Response to Febridx Clia Waiver Application

THOMSON REUTERS

BRIEF-Lumos Diagnostics Loss For Half-Year Attributable $4.9 Million

Lumos Diagnostics Holdings Fiscal H1 Revenue Falls Slightly; Shares Up 3%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LDX.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.105,"timestamp":1787292720000,"preClose":0.105,"halted":0,"volume":769561,"delay":0,"changeRate":0,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":375602340,"shares":944389135,"eps":-0.018,"marketStatus":"Not Yet Opened","change":0,"latestTime":"08-21 16:12:00 AEST","open":0.11,"high":0.11,"low":0.1,"amount":80625,"amplitude":0.095238,"askPrice":0.11,"askSize":224999,"bidPrice":0.1,"bidSize":1042244,"shortable":3,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.105,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.3831890165727063,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"LDX.AU","preClose":0.105,"auctionPrice":0.105,"auctionVolume":1129,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600775}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":375602340,"roa":"-29.18%","roe":"-123.27%","lyrEps":-0.01056,"volumeRatio":1.3831890165727063,"shares":944389135,"dividePrice":0,"high":0.11,"amplitude":0.095238,"preClose":0.105,"low":0.1,"week52Low":0.076,"pbRate":"13.58","psRate":"5.82","week52High":0.33,"institutionHeld":0,"latestPrice":0.105,"committee":0.6449,"eps":-0.018,"divideRate":0,"volume":769561,"delay":0,"ttmEps":-0.018,"open":0.11,"prevYearClose":0.285,"prevWeekClose":0.11,"prevMonthClose":0.1,"prevQuarterClose":0.105,"fiveDayClose":0.11,"twentyDayClose":0.11,"sixtyDayClose":0.115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-27","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785110400000,"name":null,"time":"","dateTimestamp":1785074400000,"actualEps":null},{"date":"2026-04-20","symbol":"LDX.AU","type":"earning","reportTimeType":"post","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776643200000,"name":null,"time":"Post-Mkt","dateTimestamp":1776607200000,"actualEps":null},{"date":"2025-08-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null},{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2625604289","title":"Lumos Diagnostics Secures Three-Year Contract to Manufacture Mold Analyzer; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625604289","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625604289?lang=en_us&edition=fundamental","pubTime":"2026-04-08 08:45","pubTimestamp":1775609125,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics  secured a three-year contract to manufacture Micro-Pak's Mold Analyzer system, according to a Wednesday filing with the Australian bourse.The company received the first purchase order worth $250,000 under the agreement, the filing said.Lumos developed the mold analyzer system for Micro-Pak.Its shares rose 3% in morning trade on Wednesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625624259","title":"Lumos Diagnostics - First Purchase Order of a$250,000 Under Three-Year Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2625624259","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625624259?lang=en_us&edition=fundamental","pubTime":"2026-04-08 07:45","pubTimestamp":1775605548,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q12C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625496244","title":"Lumos Diagnostics Holdings Ltd - Secures Contract to Manufacture Micro-Pak Mold Analyzer System","url":"https://stock-news.laohu8.com/highlight/detail?id=2625496244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625496244?lang=en_us&edition=fundamental","pubTime":"2026-04-08 07:45","pubTimestamp":1775605548,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nFWN40Q12C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624848550","title":"Lumos Diagnostics Holdings Receives Largest Ever Purchase Order of $1.3 Million, Shares Up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624848550","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624848550?lang=en_us&edition=fundamental","pubTime":"2026-04-01 09:27","pubTimestamp":1775006826,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings (ASX:LDX) said it has received its largest-ever purchase order from US exclusive distributor PHASE Scientific, valued at $1.3 million for its FebriDx product, according to a Wednesday Australian bourse filing.The company's shares rose 9% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624055557","title":"BRIEF-Lumos Diagnostics Receives Largest Febridx Order To Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2624055557","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624055557?lang=en_us&edition=fundamental","pubTime":"2026-04-01 09:21","pubTimestamp":1775006489,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Receives Largest Febridx Order To DateApril 1 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:LUMOS RECEIVES LARGEST FEBRIDX ORDER TO DATEFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40J1W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624755454","title":"Lumos Diagnostics Holdings Ltd - Lumos Receives Largest Febridx Order to Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2624755454","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624755454?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:47","pubTimestamp":1775000873,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624554525","title":"Lumos Diagnostics - Phase Lodges Purchase Order Valued at US$1.3 Mln for Febridx","url":"https://stock-news.laohu8.com/highlight/detail?id=2624554525","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624554525?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:47","pubTimestamp":1775000873,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1W5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622815950","title":"Lumos Diagnostics to Raise AU$20 Million via Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622815950","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622815950?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:44","pubTimestamp":1774575879,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics (ASX:LDX) received firm commitments to raise AU$20 million through the placement of up to 88.9 million new shares at AU$0.225 apiece, according to a Friday filing with the Australian","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622741813","title":"BRIEF-Lumos Diagnostics Announces Share Purchase Plan To Raise About A$2.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622741813","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622741813?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:27","pubTimestamp":1774574878,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Announces Share Purchase Plan To Raise About A$2.0 MillionMarch 27  - Lumos Diagnostics Holdings Ltd LDX.AX:ANNOUNCES SHARE PURCHASE PLAN TO RAISE ABOUT A$2.0 MILLIONOFFER PRICE AT A$0.225 PER SHAREFurther company coverage: LDX.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40E0ZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622818799","title":"BUZZ-Australia's Lumos Diagnostics gains as US FDA grants waiver for FebriDx","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818799","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622818799?lang=en_us&edition=fundamental","pubTime":"2026-03-27 08:55","pubTimestamp":1774572904,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Lumos Diagnostics gains as US FDA grants waiver for FebriDx** Shares of Australia's Lumos Diagnostics LDX.AX gain as much as 7.6% to A$0.285, their highest point since March 19** The ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL6N40F01X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622721892","title":"Lumos Diagnostics Holdings  - Announces Share Purchase Plan to Raise About a$2.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622721892","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622721892?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:09","pubTimestamp":1774566541,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0ZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622041892","title":"Lumos Diagnostics - Offer Price at a$0.225 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622041892","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622041892?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:09","pubTimestamp":1774566541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0ZS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622489272","title":"Lumos Diagnostics Holdings Ltd - US FDA Grants Clia Waiver for Febridx","url":"https://stock-news.laohu8.com/highlight/detail?id=2622489272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622489272?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:08","pubTimestamp":1774566494,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E15N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622019503","title":"BRIEF-Lumos Diagnostics Seeks Trading Halt Pending Update On FDA Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2622019503","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622019503?lang=en_us&edition=fundamental","pubTime":"2026-03-25 06:22","pubTimestamp":1774390938,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Seeks Trading Halt Pending Update On FDA Response March 25 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:SEEKS TRADING HALT PENDING UPDATE ON FDA RESPONSE TO FEBRIDX CLIA WAIVER APPLICATIONFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C16H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622019545","title":"Lumos Diagnostics Holdings - Seeks Trading Halt Pending Update on FDA Response to Febridx Clia Waiver Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2622019545","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622019545?lang=en_us&edition=fundamental","pubTime":"2026-03-25 06:21","pubTimestamp":1774390892,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C16H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614800607","title":"BRIEF-Lumos Diagnostics Loss For Half-Year Attributable $4.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614800607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614800607?lang=en_us&edition=fundamental","pubTime":"2026-02-27 09:38","pubTimestamp":1772156288,"startTime":"0","endTime":"0","summary":"BRIEF-Lumos Diagnostics Loss For Half-Year Attributable $4.9 MillionFeb 27 (Reuters) - Lumos Diagnostics Holdings Ltd LDX.AX:LOSS FOR HALF-YEAR ATTRIBUTABLE $4.9 MILLIONHY  REVENUES FROM ORDINARY ACTIVITIES $6.1 MILLIONFurther company coverage: LDX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nFWN3ZM27J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614623005","title":"Lumos Diagnostics Holdings Fiscal H1 Revenue Falls Slightly; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614623005","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614623005?lang=en_us&edition=fundamental","pubTime":"2026-02-27 08:48","pubTimestamp":1772153294,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  said its revenue for the six months ended Dec. 31, 2025, came in at AU$6.1 million, compared with AU$6.3 million in the prior-year period, according to a Friday Australian bourse filing.Under its development agreement with Hologic, the company is working on the development of Hologic's fFN diagnostic product for pre-term birth, including adapting the test for use on Lumos' proprietary reader platform. The scope of work was expanded on three occasions, increasing total potential milestone payments to between AU$6.5 million and AU$7 million. The estimated project completion timeline was extended to February 2027.The reduction in services revenue of AU$1 million during the period was driven by less revenue recognized from the intellectual property agreement with Hologic.Lumos Diagnostics Holdings' shares rose nearly 3% in recent trading on Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":37,"code":"91000000","status":"200"}]}}